Your browser doesn't support javascript.
loading
New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.
Niu, Leilei; Liu, Liping; Yang, Shengli; Ren, Jianwei; Lai, Paul B S; Chen, George G.
Afiliación
  • Niu L; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, China; Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
  • Liu L; Department of Hepatobiliary and Pancreas Surgery, The Second Clinical Medical College of Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong Province, China.
  • Yang S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Ren J; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, China; Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
  • Lai PBS; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, China. Electronic address: paullai@surgery.cuhk.edu.hk.
  • Chen GG; Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, China; Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, Guangdong, China. Electronic address: gchen@cuhk.edu.hk.
Biochim Biophys Acta Rev Cancer ; 1868(2): 564-570, 2017 Dec.
Article en En | MEDLINE | ID: mdl-29054475

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Compuestos de Fenilurea / Niacinamida / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Biochim Biophys Acta Rev Cancer Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Compuestos de Fenilurea / Niacinamida / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Biochim Biophys Acta Rev Cancer Año: 2017 Tipo del documento: Article País de afiliación: China